Abstracts tagged "fibromyalgia"

Abstract Number: 3086 • 2015 ACR/ARHP Annual Meeting
The Same Multidimensional Patient Health Assessment Questionnaire Used to Assess RAPID3 in Rheumatoid Arthritis, Osteoarthritis and Other Rheumatic Diseases Can Provide Quantitative Clues to Recognize and Document Comorbid Fibromyalgia
Kathryn A. Gibson¹, Annie Huang² and Theodore Pincus², ¹Liverpool Hospital, Liverpool, Australia, ²Rheumatology, Rush University Medical Center, Chicago, IL
Background/Purpose: An MDHAQ/RAPID3 (Multidimensional Health Assessment Questionnaire/Routine Assessment of Patient Index Data) is a 2 sided, 1 page questionnaire which is completed by patients in…
Abstract Number: 2294 • 2015 ACR/ARHP Annual Meeting
Re-Scoring the 2011 Fibromyalgia Survey Criteria to be a Better Surrogate for Pain Centralization
Stephanie Moser¹, Chad Brummett², Alexander Tsodikov³, David A. Williams⁴ and Daniel J. Clauw², ¹Department of Anesthesiology, University of Michigan, Ann Arbor, MI, ²Anesthesiology, University of Michigan, Ann Arbor, MI, ³Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, ⁴Anesthseiology, University of Michigan, Ann Arbor, MI
Background/Purpose: The 2011 Fibromyalgia (FM) Survey Criteria is comprised of measures of widespread pain (0-19 body areas) and 6 co-morbid symptoms (scored 0-12). The measure…
Abstract Number: 3090 • 2015 ACR/ARHP Annual Meeting
Fibromyalgia Predicts Two-Year Changes in Functional Status in Rheumatoid Arthritis Patients
Hyein Kim¹, Jing Cui², M Frits³, C Iannaccone⁴, Jonathan S. Coblyn³, N Shadick⁵, Michael Weinblatt⁴ and Yvonne C. Lee⁶, ¹Western University, London, ON, Canada, ²Division of Rheumatology, Immunology, and Allergy, Brigham & Women's Hospital, Boston, MA, ³Brigham & Women's Hospital, Boston, MA, ⁴Brigham and Women's Hospital, Boston, MA, ⁵Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, ⁶Rheumatology Immunology & Allergy, Brigham and Women's Hospital, Boston, MA
Background/Purpose: The prevalence of fibromyalgia (FM) is 10-20% in rheumatoid arthritis (RA) patients, compared to 2-3% in the general population. Previous studies have shown that…
Abstract Number: 70 • 2015 ACR/ARHP Annual Meeting
Data from Brazilian Fibromyalgia Patients Registry (EPIFIBRO) in 2014
Jose Eduardo Martinez^1,2, Marcelo C. Rezende^3,4, Eduardo Paiva^4,5, Daniel Pollak^4,6, Milton Helfenstein Jr^4,7, Jose Roberto Provenza^4,8, Aline Ranzolin^4,9, Roberto E Heymann^4,10, Eduardo L. Ribeiro^4,11, Marcos Renato Assis^4,12 and Eduardo J. R. Souza^4,13, ¹Sociedade Brasileira de Reumatologia, Sorocaba, Brazil, ²Medicine, Pontifical Catholic University of Sao Paulo, Sorocaba, Brazil, ³Santa Casa de Campo Grande, Campo Grande, Brazil, ⁴Sociedade Brasileira de Reumatologia, São Paulo, Brazil, ⁵Rheumatology, Universidade Federal do Parana, Curitiba, Brazil, ⁶Rheumathology, Universidade Federal de São Paulo, São Paulo, Brazil, ⁷RUA JOAO DE LACERDA SOARES, 90, Unifesp, Sao Paulo, Brazil, ⁸Rheumatology, Pontifícia Universidade Católica de Campinas, Campinas, Brazil, ⁹Hospital das Clínicas - Universidade Federal de Pernambuco, Recife, Brazil, ¹⁰Universidade Federal de São Paulo, São Paulo, Brazil, ¹¹Instituto de Previdência dos Servidores do Estado de Minas Gerais, Belo Horizonte, Brazil, ¹²Faculdade de Medicina de Marilia, Marilia, Brazil, ¹³Santa Casa de Belo Horizonte, Belo Horizonte, Brazil
Background/Purpose: –The Brazilian registry on fibromyalgia syndrome (EPIFIBRO) included 810 patients who satisfied the American College of Rheumatology Classification Criteria for Fibromyalgia (ACR1990) at the…
Abstract Number: 2299 • 2015 ACR/ARHP Annual Meeting
Association Between Catechol-O-Methyl Transferase Gene Polymorphisms and Fibromyalgia in a Korean Population: A Case-Control Study
Yi-Rang Yim¹, Dong-Jin Park², Seong-Ho Kim³, Seong-Su Nah⁴, Ji Hyun Lee⁵, Seong-Kyu Kim⁶, Yeon-Ah Lee⁷, Seung-Jae Hong⁸, Hyun-Sook Kim⁹, Hye-Soon Lee¹⁰, Hyoun-Ah Kim¹¹, Chung-Il Joung¹², Sang-Hyon Kim¹³ and Shin-Seok Lee¹, ¹Chonnam National University Medical School and Hospital, Gwangju, South Korea, ²Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, South Korea, ³Inje University Haeundae Paik Hospital, Busan, South Korea, ⁴Soonchunhyang University, College of Medicine, Cheonan, South Korea, ⁵Internal Medicine, Maryknoll Medical Center, Busan, South Korea, ⁶Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, South Korea, ⁷Division of Rheumatology, Department of Internal Medicine, School of Medicine, Kyung Hee University, Seoul, South Korea, ⁸Dept. of Rheumatology, #1 Hoeg, KyungHee University Medical Center, SEOUL, South Korea, ⁹Internal Medicine, College of Medicine, Chosun University, Gwangju, South Korea, ¹⁰Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ¹¹Ajou University Hospital, Suwon, South Korea, ¹²Internal Medicine, Konyang University Medical School, Daejeon, South Korea, ¹³Division of Rheumatology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, South Korea
Background/Purpose: Although polymorphisms of the catechol-O-methyl transferase (COMT) gene have been implicated in altered pain sensitivity, results concerning the association between COMT gene polymorphisms and…
Abstract Number: 3091 • 2015 ACR/ARHP Annual Meeting
A Randomized, Controlled Trial of Pregabalin in Adolescent Patients (12-17 years) with Fibromyalgia
Lesley Arnold¹, Lucinda Bateman², Kenneth N. Schikler³, Tahira Khan⁴, Lynne Pauer⁴, Pritha Bhadra Brown⁵, Marci L. Chew⁴, Andrew Clair⁵ and Joseph Scavone⁴, ¹University of Cincinnati, Cincinnati, OH, ²Bateman Horne Center, Salt Lake City, UT, ³Pediatrics, University of Louisville, Louisville, KY, ⁴Pfizer Inc, Groton, CT, ⁵Pfizer Inc., New York, NY
Background/Purpose: :Fibromyalgia (FM) is characterized by chronic widespread pain, sleep disturbance, and fatigue. Pregabalin is approved in the US in adults for the management of…
Abstract Number: 76 • 2015 ACR/ARHP Annual Meeting
Evaluating Weather’s Effect on Fibromyalgia Patients Using the Revised Fibromyalgia Impact Questionnaire and the Brief Pain Inventory
Daniel Kim¹, Ruth Chan¹, Marcal Plans² and Kevin Hackshaw¹, ¹Rheumatology & Immunology, Ohio State University, Columbus, OH, ²Food Science and Technology Department, Ohio State University, Columbus, OH
Background/Purpose: The objective of this study was to evaluate whether weather had an affect on fibromyalgia symptoms as measured by the Revised Fibromyalgia Impact Questionnaire…
Abstract Number: 2300 • 2015 ACR/ARHP Annual Meeting
Polymorphisms of Transient Receptor Potential Vanilloid (TRPV) 2 and TRPV3 Gene Polymorphisms Were Associated with Fibromyalgia in a Korean Population
Yi-Rang Yim¹, Dong-Jin Park², Seong-Ho Kim³, Seong-Su Nah⁴, Ji Hyun Lee⁵, Seong-Kyu Kim⁶, Yeon-Ah Lee⁷, Seung-Jae Hong⁸, Hyun-Sook Kim^9,10, Hye-Soon Lee¹¹, Hyoun-Ah Kim¹², Chung-Il Joung¹³, Sang-Hyon Kim¹⁴ and Shin-Seok Lee¹, ¹Chonnam National University Medical School and Hospital, Gwangju, South Korea, ²Rheumatology, Chonnam National University Medical School and Hospital, Gwangju, South Korea, ³Inje University Haeundae Paik Hospital, Busan, South Korea, ⁴Soonchunhyang University, College of Medicine, Cheonan, South Korea, ⁵Internal Medicine, Maryknoll Medical Center, Busan, South Korea, ⁶Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, South Korea, ⁷Division of Rheumatology, Department of Internal Medicine, School of Medicine, Kyung Hee University, Seoul, South Korea, ⁸Dept. of Rheumatology, #1 Hoeg, KyungHee University Medical Center, SEOUL, South Korea, ⁹Internal Medicine, College of Medicine, Chosun University, Gwangju, South Korea, ¹⁰Division of Rheumatology, Department of Internal Medicine, Soonchunhyang University of Korea, Seoul, South Korea, ¹¹Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Seoul, South Korea, ¹²Ajou University Hospital, Suwon, South Korea, ¹³Internal Medicine, Konyang University Medical School, Daejeon, South Korea, ¹⁴Division of Rheumatology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, South Korea
Background/Purpose: Fibromyalgia (FM) is a chronic pain syndrome characterized by lowered pain thresholds and other FM-related symptoms such as fatigue, anxiety and depression. Recent studies…
Abstract Number: 78 • 2015 ACR/ARHP Annual Meeting
Exploratory Analysis of Somatic Symptoms in Fibromyalgia By Multidimensional Scaling and Latent Class Analysis
Marco Antivalle¹, Michele Battellino¹, Alberto Batticciotto¹, MariaChiara Ditto¹, Alessandra Mutti¹, Valentina Varisco¹, Federica Rigamonti¹, Fabiola Atzeni¹ and Piercarlo Sarzi-Puttini², ¹Rheumatology, L. Sacco University Hospital, Milano, Italy, ²Rheumatology Unit, L. Sacco University Hospital, Milano, Italy
Background/Purpose: Attempts to individuate subsets of fibromyalgia patients based on the aggregation of different symptoms have so far produced conflicting results. The 2010 preliminary diagnostic…
Abstract Number: 2301 • 2015 ACR/ARHP Annual Meeting
Facing Fibromyalgia; How Patients Describe Their Symptoms Based on a Retrospective Evaluation of a Patient Survey and Vitality Assessment in Clinical Trials
Andrew Clair¹, Lynne Pauer² and Elizabeth Masters¹, ¹Pfizer Inc., New York, NY, ²Pfizer Inc, New London, CT
Background/Purpose: Fibromyalgia (FM) is a common chronic widespread pain disorder with comorbid symptoms of fatigue, sleep disturbance, cognitive dysfunction and depression. It is believed to…
Abstract Number: 80 • 2015 ACR/ARHP Annual Meeting
Paresthesias in Fibromyalgia Patients
Robert S. Katz¹, Lauren Kwan², Kelli Davis² and Jessica L. Polyak², ¹Rush University Medical Center, Chicago, IL, ²Rheumatology Associates S.C., Chicago, IL
Background/Purpose: Paresthesias are common in patients with fibromyalgia. We evaluated the symptoms of numbness and tingling in fibromyalgia patients and rheumatic disease controls without…
Abstract Number: 2302 • 2015 ACR/ARHP Annual Meeting
The Impact of Prior Fibromyalgia Treatment on the Response to Pregabalin in Fibromyalgia Clinical Trials
Lynne Pauer¹, Andrew Clair², Pritha Bhadra Brown², Marie Ortiz² and Joseph Scavone¹, ¹Pfizer Inc, Groton, CT, ²Pfizer Inc., New York, NY
Background/Purpose: Fibromyalgia (FM) is a chronic, widespread pain disorder for which Lyrica is an approved treatment. Antidepressants, gabapentin, muscle relaxants, and opioids are frequently used…
Abstract Number: 84 • 2015 ACR/ARHP Annual Meeting
Sexual Dimorphism in the Association Between Multi-Site Pain and Other Fibromyalgia Features: an Analysis of Data from Three UK Population-Based Studies
Linda E. Dean¹, Lesley Arnold², Robert Bennett³, Leslie J. Crofford⁴, Don Goldenberg⁵, Elisa Flüß¹, Daniel J. Clauw⁶, Mary-Ann Fitzcharles⁷, Eduardo Paiva⁸, Roland Staud⁹ and Gary J. Macfarlane¹, ¹Musculoskeletal Research Collaboration (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, ²University of Cincinnati, Cincinnati, OH, ³SN-Office of Research & Development, Oregon Health & Science Univ, Portland, OR, ⁴Medicine, Vanderbilt University, Nashville, TN, ⁵Newton-Wellesley Hospital, Newton, MA, ⁶Anesthesiology, University of Michigan, Ann Arbor, MI, ⁷MGH, Montreal, QC, Canada, ⁸Rheumatology, Universidade Federal do Parana, Curitiba Parana, Brazil, ⁹University of Florida, Gainesville, FL
Background/Purpose: The 2011 modification of the preliminary 2010 American College of Rheumatology criteria for fibromyalgia require the self-report of multi-site pain in addition to a…
Abstract Number: 2305 • 2015 ACR/ARHP Annual Meeting
Relationship Between Anxiety, Depression, Sleep, Fibromyalgia and BMI in Patients with Rheumatic Disease
Shazia Bég¹ and Ali Ahmad², ¹Rheumatology, University of Central Florida, Orlando, FL, ²University of Central Florida, Orlando, FL
Background/Purpose: Patients with rheumatic diseases often have comorbidities that complicate their psychological well-being and affect prognosis. In this study, we looked at 216 patients with…
Abstract Number: 119 • 2015 ACR/ARHP Annual Meeting
Triage in Chronic Rheumatic Diseases: Quantitative Physician Estimates for Inflammation (Reversible), Damage (Irreversible), and Distress in Patients with Rheumatoid Arthritis, Osteoarthritis, and Fibromyalgia Seen in Usual Care
Isabel Castrejón¹, Kathryn A. Gibson², Ruchi Jain¹, Annie Huang¹, Joel A. Block³ and Theodore Pincus¹, ¹Rheumatology, Rush University Medical Center, Chicago, IL, ²Liverpool Hospital, Liverpool, Australia, ³Rush University Medical Center, Chicago, IL
Background/Purpose: A physician estimate of a patient’s global status (DOCGL) often is most often the most efficient of all 7 rheumatoid arthritis (RA) core data…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].